ReviewLife (Basel, Switzerland)2023

Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review.

Krasimir Kraev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.